Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher C. Schreiber currently holds 88,238 shares of Akers Biosciences, Inc. (AKER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher C. Schreiber has been a net neutral trader of AKER stock. They have purchased $0 and sold $0 worth of shares.
Christopher C. Schreiber's most recent insider trade was on Apr 16, 2021, when they sold 46,113 shares at $4.94 per share.
Christopher C. Schreiber serves as Executive at Akers Biosciences, Inc. (AKER). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Christopher C. Schreiber holds the position of Executive at Akers Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Christopher C. Schreiber has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher C. Schreiber was on Apr 16, 2021, when they sold $227.8K worth of MYMD shares. This transaction involved 46,113 shares at $4.94 per share.
Christopher C. Schreiber currently owns 88,238 shares of Akers Biosciences, Inc. (AKER), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher C. Schreiber's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher C. Schreiber has 3 Form 4 filings on record as an insider at Akers Biosciences, Inc..
Set alerts for Christopher C. Schreiber and 40,000+ other insiders.